Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00932100 · ClinicalTrials.gov registry record · Phase 2
A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
A Phase 2 study, sponsored by Regado Biosciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 640
- Enrollment target
NCT00932100: Completed Phase 2 study, sponsored by Regado Biosciences.
NCT00932100 is a Phase 2 study that has completed, run by Regado Biosciences. The registered enrollment target is 640 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (381% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00932100, a Phase 2 study, has completed, sponsored by Regado Biosciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 640 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the REG1 anticoagulation System in Acute Coronary Syndrome (ACS) patients undergoing cardiac catheterization.
Interventions
- DRUG Heparin
- DRUG REG1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-01 |
| Phase | Phase 2 |
What the finished NCT00932100 record still lists
NCT00932100 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (381% higher).
The record links to 0 conditions, and to 2 interventions - of which Heparin is the first listed.
NCT00932100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00932100 about?
NCT00932100 is a clinical study titled "A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome". The purpose of this study is to evaluate the safety and efficacy of the REG1 anticoagulation System in Acute Coronary Syndrome (ACS) patients undergoing cardiac catheterization.
What is the current status of trial NCT00932100?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 640 participants. The study started on 2009-07. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00932100?
The interventions under investigation include: Heparin (DRUG), REG1 (DRUG).
Who is sponsoring clinical trial NCT00932100?
This trial is sponsored by Regado Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00932100's enrollment target sits among peer trials
640 51st of 2000 higher than 1,950 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia